Winteam to Buy Tongjitang Medicine for $393 Million

Winteam Pharmaceutical Group Ltd., a maker of drugs in China, will buy a producer of traditional Chinese medicine for as much as HK$3.05 billion ($393 million) to gain products including an osteoporosis treatment.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.